Suchergebnisse - "Miloslavsky, Eli"

PubPharm (8)

1

Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

enthalten in: Arthritis care & research | 2023

von Wallace, Z. | Stone, J. | Fu, X. | +5

2

Use of rituximab in the treatment of mucous membrane pemphigoid : An analytic review

enthalten in: Autoimmunity reviews | 2022

von Farooq, M. | Miloslavsky, E. | Konikov, N. | +1

3

Management of ANCA associated vasculitis

enthalten in: BMJ (Clinical research ed.) | 2020

von Wallace, Z. | Miloslavsky, E.

4

Reducing glucocorticoid duration in ANCA-associated vasculitis : A pilot trial

enthalten in: Seminars in arthritis and rheumatism | 2018

von Miloslavsky, E. | Niles, J. | Wallace, Z. | +4

5

Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

enthalten in: Arthritis care & research | 2017

von Wallace, Z. | Miloslavsky, E. | Cascino, M. | +14

6

Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's) : Distinct Patient Subsets

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2016

von Miloslavsky, E. | Lu, N. | Unizony, S. | +13

CommentIn: Arthritis Rheumatol. 2016 Dec;68(12):2837-2840. - PMID 27588958

7

Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

enthalten in: Annals of the rheumatic diseases | 2016

von Unizony, S. | Villarreal, M. | Miloslavsky, E. | +18

8

Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2015

von Unizony, S. | Lim, N. | Phippard, D. | +15

1
[1]